- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07676747
Ralation Between Cardiorespiratory Fitness and Mean Corrected Intraocular Pressure
Cardiorespiratory Fitness and Mean Corrected Intraocular Pressure: A Cross-Sectional Study in a Normotensive Health Check-up Population
Objective: To investigate the association between cardiorespiratory fitness and mean corrected intraocular pressure (IOP) in a normotensive health check-up population, and to evaluate potential differences across age and sex strata.
Methods: This cross-sectional study consecutively enrolled adults aged 18-70 years who completed cardiorespiratory fitness testing and ophthalmologic examinations at the Health Management Center of Sichuan Provincial People's Hospital between July 1, 2019 and December 31, 2025. Individuals were excluded if they had a history of glaucoma, ocular diseases interfering with IOP measurement, systemic diseases or medications affecting IOP, contraindications to fitness testing, or abnormal blood pressure. A final sample of 2,921 normotensive individuals was included. Cardiorespiratory fitness was assessed by estimated maximal oxygen uptake (VO₂max). After age- and sex-stratified grouping, low cardiorespiratory fitness was used as the reference, and the remainder were defined as the moderate-to-high cardiorespiratory fitness group. The primary outcome was the mean corrected IOP of both eyes. Multiple imputation, multivariable linear regression, and age- and sex-stratified analyses were used to evaluate the association.
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
Sichuan
-
Chengdu, Sichuan, China, 610000
- Sichuan Provinvial People's HSichuan Academy of Medical Sciences & Sichuan Provincial People's Hospital( SAMS&SPPH,Affiliated Hospital of UESTC)ospital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
Inclusion Criteria:
- Age 18-70 years;
- Ability to complete standardized cardiorespiratory fitness testing and provide valid data; and
- Ability to cooperate with a comprehensive ophthalmologic examination.
Exclusion Criteria:
- Any history of glaucoma or ocular hypertension, or detection of glaucoma suspect signs such as cup-to-disc ratio ≥0.7, interocular cup-to-disc ratio asymmetry >0.2, or localized retinal nerve fiber layer defects;
- Ocular diseases or surgical history affecting IOP measurement or optic nerve head assessment, such as corneal disease, uveitis, intraocular surgery, high myopia (spherical equivalent ≤ -6.00 D), or other optic nerve/retinal diseases;
- Systemic diseases that could significantly interfere with IOP, optic nerve blood supply, or cardiorespiratory function, such as uncontrolled diabetes mellitus, severe cardiovascular or cerebrovascular disease, or chronic obstructive pulmonary disease;
- Current use of topical or systemic medications known to affect IOP, including IOP-lowering eyedrops, systemic beta-blockers, or glucocorticoids;
- Contraindications to cardiorespiratory fitness testing, such as severe musculoskeletal disorders or uncontrolled arrhythmias;
- A documented history of hypertension, current use of antihypertensive medications, or abnormal blood pressure on a single measurement that did not normalize on re-examination (systolic blood pressure [SBP] ≥140 mmHg or diastolic blood pressure [DBP] ≥90 mmHg); and
- Missing key study variables that precluded further analysis.
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
low cardiorespiratory fitness
Cardiorespiratory fitness levels were classified based on age- and sex-stratified percentiles of VO₂max in the present study sample.
VO₂max ≤ the 25th percentile for the same age group and sex was defined as low cardiorespiratory fitness.
|
Intraocular pressure (IOP) was measured in both eyes using a non-contact tonometer (CT-1P, Topcon Corporation, Tokyo, Japan).
The corrected IOP was automatically calculated by the device's built-in algorithm based on central corneal thickness.
In Chinese healthy adults, corneal thickness is significantly associated with sex and age, which has important clinical implications for the correction of IOP measurements.
To minimize the influence of diurnal fluctuation on IOP measurements, all IOP assessments were uniformly scheduled between 7:30 AM and 11:00 AM.
Two measurements were taken for each eye and the average was recorded.
The mean corrected IOP, defined as the average of the corrected IOP values of both eyes, was used as the primary outcome measure in this study.
|
|
Moderate-to-high cardiorespiratory fitness
The remainder were defined as moderate-to-high cardiorespiratory fitness.
|
Intraocular pressure (IOP) was measured in both eyes using a non-contact tonometer (CT-1P, Topcon Corporation, Tokyo, Japan).
The corrected IOP was automatically calculated by the device's built-in algorithm based on central corneal thickness.
In Chinese healthy adults, corneal thickness is significantly associated with sex and age, which has important clinical implications for the correction of IOP measurements.
To minimize the influence of diurnal fluctuation on IOP measurements, all IOP assessments were uniformly scheduled between 7:30 AM and 11:00 AM.
Two measurements were taken for each eye and the average was recorded.
The mean corrected IOP, defined as the average of the corrected IOP values of both eyes, was used as the primary outcome measure in this study.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Mean corrected intraocular pressure (IOP) of both eyes
Time Frame: same day 1
|
same day 1
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Ocular hypertension
Time Frame: same day 1
|
IOP > 21 mmHg in one eye
|
same day 1
|
Collaborators and Investigators
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- SichuanAMS-2026-280
- 2023QN15 (Other Grant/Funding Number: Sichuan Academy of Medical Sciences & Sichuan Provincial People's Hospital( SAMS&SPPH,Affiliated Hospital of UESTC))
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Cardiorespiratory Fitness
-
Riphah International UniversityCompletedPhysical Fitness | Cardiorespiratory FitnessPakistan
-
Wilfrid Laurier UniversityRecruitingCardiorespiratory FitnessCanada
-
University of CopenhagenVentriJect ApSCompletedCardiorespiratory Fitness TestDenmark
-
Riphah International UniversityRecruiting
-
Dr. Soetomo General HospitalCompletedCardiorespiratory FitnessIndonesia
-
Duke UniversityCompleted
-
University of NottinghamCompletedCardiorespiratory FitnessUnited Kingdom
-
University of British ColumbiaCompletedCardiorespiratory FitnessCanada
-
Robert Ross, PhDRecruiting
Clinical Trials on Mean corrected intraocular pressure (IOP) of both eyes
-
University of ZurichCompleted
-
University Hospital TuebingenUniversity Hospital FreiburgCompletedNon-arteritic Ischemic Optic NeuropathyGermany
-
Aristotle University Of ThessalonikiCompletedGlaucoma | Ocular Surface DiseaseGreece